Correlation Between Vyne Therapeutics and Carmell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and Carmell Therapeutics, you can compare the effects of market volatilities on Vyne Therapeutics and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and Carmell Therapeutics.

Diversification Opportunities for Vyne Therapeutics and Carmell Therapeutics

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vyne and Carmell is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and Carmell Therapeutics go up and down completely randomly.

Pair Corralation between Vyne Therapeutics and Carmell Therapeutics

Given the investment horizon of 90 days Vyne Therapeutics is expected to generate 0.43 times more return on investment than Carmell Therapeutics. However, Vyne Therapeutics is 2.3 times less risky than Carmell Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.1 per unit of risk. If you would invest  241.00  in Vyne Therapeutics on September 2, 2024 and sell it today you would earn a total of  55.00  from holding Vyne Therapeutics or generate 22.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vyne Therapeutics  vs.  Carmell Therapeutics

 Performance 
       Timeline  
Vyne Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Vyne Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Vyne Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Carmell Therapeutics is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Vyne Therapeutics and Carmell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vyne Therapeutics and Carmell Therapeutics

The main advantage of trading using opposite Vyne Therapeutics and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.
The idea behind Vyne Therapeutics and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories